AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction

NCT01915407 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2013-08-02

No results posted yet for this study

Summary

To test the AggreGuide A-100 AA Assay's effectiveness for detecting aspirin induced platelet dysfunction.

Conditions

  • Platelet Dysfunction Due to Aspirin Ingestion

Sponsors & Collaborators

  • Aggredyne, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01915407 on ClinicalTrials.gov